Literature DB >> 21881124

Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection.

John Goulding1, Alexandra Godlee, Seema Vekaria, Markus Hilty, Robert Snelgrove, Tracy Hussell.   

Abstract

BACKGROUND: Previous studies have shown that the interaction of CD200R, a myeloid inhibitory receptor, with its ligand, CD200, is critical in the control of innate immune activation in the lung. METHODS AND
RESULTS: Using a mouse model of bacterial superinfection following influenza, we show that an absence of CD200R (a negative regulator highly expressed by macrophages and dendritic cells), restricts commensal and exogenous bacterial invasiveness and completely prevents the mortality observed in wild-type mice. This benefit is due to a heightened innate immune response to influenza virus in cd200r knockout mice that limits immune pathogenesis and viral load. In wild-type mice, apoptotic cells expressing CD200 that we believe contribute to the suppressed innate immune response to bacteria dominate during the resolution phase of influenza-induced inflammation. We also show for the first time the presence of a variety of previously unidentified bacterial species in the lower airways that are significantly adjusted by influenza virus infection and may contribute to the pathophysiology of disease.
CONCLUSIONS: The interaction of CD200 with CD200R therefore contributes to the hyporesponsive innate immune state following influenza virus infection that predisposes to secondary bacterial infection, a phenomenon that has the potential for immune modulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881124      PMCID: PMC3164429          DOI: 10.1093/infdis/jir467

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

Review 1.  Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut.

Authors:  David Artis
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

2.  Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria.

Authors:  M L Colamussi; M R White; E Crouch; K L Hartshorn
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

3.  Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Mary J Pantin-Jackwood; Stacey Schultz-Cherry; Alicia Solórzano; Nico Van Rooijen; Jacqueline M Katz; Christopher F Basler
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Preparation and functional properties of monoclonal antibodies to human, mouse and rat OX-2.

Authors:  R Ragheb; S Abrahams; R Beecroft; J Hu; J Ni; V Ramakrishna; G Yu; R M Gorczynski
Journal:  Immunol Lett       Date:  1999-06-01       Impact factor: 3.685

5.  A critical function for CD200 in lung immune homeostasis and the severity of influenza infection.

Authors:  Robert J Snelgrove; John Goulding; Arnaud M Didierlaurent; Daphne Lyonga; Seema Vekaria; Lorna Edwards; Emily Gwyer; Jonathon D Sedgwick; A Neil Barclay; Tracy Hussell
Journal:  Nat Immunol       Date:  2008-07-27       Impact factor: 25.606

6.  Heterogeneity in the CD200R paired receptor family.

Authors:  Munir Akkaya; A Neil Barclay
Journal:  Immunogenetics       Date:  2009-12-05       Impact factor: 2.846

7.  Distribution and expression of CD200 in the rat respiratory system under normal and endotoxin-induced pathological conditions.

Authors:  Ya-Fen Jiang-Shieh; Hsiung-Fei Chien; Chiu-Yun Chang; Tsui-Shan Wei; Mei-Miao Chiu; Hui-Min Chen; Ching-Hsiang Wu
Journal:  J Anat       Date:  2010-01-07       Impact factor: 2.610

8.  Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection.

Authors:  Ulf Dittmer; Tanja Werner; Anke R M Kraft
Journal:  Viral Immunol       Date:  2008-12       Impact factor: 2.257

9.  The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains.

Authors:  Deborah Hatherley; A Neil Barclay
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

10.  Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

Authors:  Arnaud Didierlaurent; John Goulding; Seema Patel; Robert Snelgrove; Lionel Low; Magali Bebien; Toby Lawrence; Leonie S van Rijt; Bart N Lambrecht; Jean-Claude Sirard; Tracy Hussell
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

View more
  52 in total

Review 1.  Control of local immunity by airway epithelial cells.

Authors:  M Weitnauer; V Mijošek; A H Dalpke
Journal:  Mucosal Immunol       Date:  2015-12-02       Impact factor: 7.313

Review 2.  The immunology of influenza virus-associated bacterial pneumonia.

Authors:  Keven M Robinson; Jay K Kolls; John F Alcorn
Journal:  Curr Opin Immunol       Date:  2015-02-24       Impact factor: 7.486

3.  IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and Streptococcus pneumoniae Coinfection.

Authors:  Shruti Bansal; Vijaya Kumar Yajjala; Christopher Bauer; Keer Sun
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

Review 4.  The price of immunity.

Authors:  Romina S Goldszmid; Giorgio Trinchieri
Journal:  Nat Immunol       Date:  2012-09-18       Impact factor: 25.606

Review 5.  Secondary bacterial infections in influenza virus infection pathogenesis.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 6.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

Review 7.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

8.  Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.

Authors:  Dennis W Metzger; Yoichi Furuya; Sharon L Salmon; Sean Roberts; Keer Sun
Journal:  J Infect Dis       Date:  2015-02-03       Impact factor: 5.226

9.  Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Authors:  Stoyan Ivanov; Joelle Renneson; Josette Fontaine; Adeline Barthelemy; Christophe Paget; Elodie Macho Fernandez; Fany Blanc; Carl De Trez; Laurye Van Maele; Laure Dumoutier; Michel-René Huerre; Gérard Eberl; Mustapha Si-Tahar; Pierre Gosset; Jean Christophe Renauld; Jean Claude Sirard; Christelle Faveeuw; François Trottein
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 10.  The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis.

Authors:  Mubing Duan; Margaret L Hibbs; Weisan Chen
Journal:  Immunol Cell Biol       Date:  2016-09-27       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.